SCC
CLB icon

Spring Creek Capital’s Core Laboratories CLB Stock Holding History

Spring Creek Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,844
Closed -$738K – 160
2018
Q2 		$738K Buy
+5,844
New +$711K 0.09% 238

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Spring Creek Capital's CLB Position: Q3 2018 in Review

Spring Creek Capital sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 5,844 shares — an estimated $738K sold.

Spring Creek Capital first reported a position in CLB in Q2 2018 and held it in 1 quarter. The position peaked at $738K in Q2 2018. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Spring Creek Capital reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Spring Creek Capital sold 5,844 Core Laboratories shares in Q3 2018, an estimated $738K.
  • Spring Creek Capital first reported a position in Core Laboratories in Q2 2018 and held it in 1 quarter.
  • Spring Creek Capital's Core Laboratories position peaked at $738K in Q2 2018.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.